Xtant Medical Holdings XTNT Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Orthobiologics | $72.89M+9.7% | $66.42M+13.3% | $58.61M+24.3% | $47.13M+11.5% | |
| Spinal Implant | $42.31M-14.3% | $49.35M+50.9% | $32.7M+202% | $10.83M-16.0% | |
| Revenue by Geography | |||||
| Non Us | $11.48M— | —— | —— | —— | |
| US | $122.45M+16.0% | $105.52M+22.9% | $85.86M+50.2% | $57.16M+4.7% | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Geography | |||||
| Non Us | -$2.55M-5.2% | -$2.43M-4,015% | $62K— | —— | |
| US | $9.55M+169% | -$13.84M-1,159% | -$1.1M+86.9% | -$8.42M-73.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Xtant Medical Holdings break its business down?
- Xtant Medical Holdings (XTNT) reports revenue by product across 2 parts — Orthobiologics and Spinal Implant. Each is extracted from the segment footnotes and tracked over time.
- Where does Xtant Medical Holdings's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Xtant Medical Holdings's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
